+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The Cardica C-Port System: clinical and angiographic evaluation of a new device for automated, compliant distal anastomoses in coronary artery bypass grafting surgery--a multicenter prospective clinical trial



The Cardica C-Port System: clinical and angiographic evaluation of a new device for automated, compliant distal anastomoses in coronary artery bypass grafting surgery--a multicenter prospective clinical trial



Journal of Thoracic and Cardiovascular Surgery 130(6): 1645-1652



The C-Port System (Cardica, Inc, Redwood City, Calif) integrates in one tool all functions necessary to enable rapid automated distal coronary anastomoses. The goal of this prospective, nonrandomized, and multicenter study is to determine the safety and efficacy of this novel anastomotic system. Five centers enrolled 133 patients awaiting elective coronary artery bypass grafting surgery. Outcome variables were intraoperative device performance, incidence of device-related adverse events, predischarge and 6-month angiographic graft patency, and 12-month clinical outcome. Independent core laboratories performed qualitative and quantitative angiographic and computed tomographic assessments. The C-Port was used to perform a vein-to-coronary anastomosis in 130 patients. Intraoperative conversion to a hand-sewn anastomosis was necessary in 11 patients because of inadequate target site preparation, inappropriate target vessel selection, or both. Inadequate blood flow related to poor runoff required conversion in 3 additional patients. Three patients died before discharge of causes unrelated to the device. At discharge, 113 patients had a C-Port implant in place, and 104 C-Port anastomoses were studied by means of angiography, resulting in 100 FitzGibbon A, 3 FitzGibbon B, and 1 FitzGibbon 0 classifications. At 6 months, one additional patient died of a device-unrelated cause, and 98 patients were evaluated by means of angiography (n = 89). Overall patency (FitzGibbon A) was 92.1%. Three C-Port anastomoses were rated FitzGibbon B, and 4 were rated FitzGibbon 0. At 12 months, 107 (98.2%) of 109 alive patients were followed up, without any reports of device-related major adverse cardiac events. The C-Port System allows for a rapid, reliable, and compliant distal anastomosis and yields favorable 6-month angiographic and 12-month clinical results when compared with published studies.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 050526189

Download citation: RISBibTeXText

PMID: 16308011

DOI: 10.1016/j.jtcvs.2005.08.033


Related references

Distal anastomotic patency of the Cardica C-PORT(R) xA system versus the hand-sewn technique: a prospective randomized controlled study in patients undergoing coronary artery bypass grafting. European Journal of Cardio-Thoracic Surgery 44(3): 512-8; Discussion 518-9, 2013

Clinical and six-month angiographic evaluation of coronary arterial graft interrupted anastomoses by use of a self-closing clip device: a multicenter prospective clinical trial. Journal of Thoracic and Cardiovascular Surgery 126(1): 168-77; Discussion 177-8, 2003

Prospective, randomized study on the use of the cardica PAS-port aortic connector system in off-pump coronary artery bypass surgery. Heart Surgery Forum 9(2): E568-E571, 2006

Distal anastomotic patency of the Cardica C-PORTR xA system vs the hand-sewn technique a prospective randomized controlled study in patients undergoing coronary artery bypass grafting. 2013

A Prospective, Randomized, Controlled Trial Of Multivessel Off Pump Coronary Artery Bypass (OPCAB) Versus Conventional Coronary Artery Bypass (C-CAB) Surgery: Clinical And Angiographic Outcomes At One Year. Innovations Technology and Techniques in Cardiothoracic and Vascular Surgery 1(4): 182-183, 2006

Initial prospective multicenter clinical trial of robotically-assisted coronary artery bypass grafting. Annals of Thoracic Surgery 72(4): 1263-8; Discussion 1268-9, 2001

Minimally invasive port-access coronary artery bypass grafting with early angiographic follow-up: Initial clinical experience. Journal of Thoracic and Cardiovascular Surgery 115(5): 1101-1110, 1998

A multicenter prospective randomized trial of a second-generation anastomotic device in coronary artery bypass surgery. Journal of Thoracic and Cardiovascular Surgery 139(3): 741-747, 2010

Total arterial off-pump coronary artery bypass grafting for revascularization of the total coronary system: clinical outcome and angiographic evaluation. Annals of Thoracic Surgery 78(4): 1304, 2004

Effect of oral vitamin C on atrial fibrillation development after isolated coronary artery bypass grafting surgery: A prospective randomized clinical trial. Cardiology Journal 21(5): 492-499, 2014

Clinical evaluation of heparin-coated circuits for routine coronary artery bypass grafting surgery: a prospective randomized study. Artificial Organs 24(8): 611-613, 2000

Port-access coronary artery bypass grafting Lessons learned in a phase I clinical trial. Circulation 94(8 Suppl. ): I52, 1996

Minimally invasive coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty with stenting in isolated high-grade stenosis of the proximal left anterior descending coronary artery: six months' angiographic and clinical follow-up of a prospective randomized study. Journal of Thoracic and Cardiovascular Surgery 124(1): 130-135, 2002

The Best Bypass Surgery Trial: rationale and design of a randomized clinical trial with blinded outcome assessment of conventional versus off-pump coronary artery bypass grafting. Contemporary Clinical Trials 28(4): 540-547, 2007

Clinical outcome of the PAS-Port® proximal anastomosis system in off-pump coronary artery bypass grafting in 201 patients. Journal of Cardiovascular Surgery 54(3): 389-395, 2013